Tuesday, July 25, 2017
Latest effort to take down federal marijuana prohibition via constitutional litigation filed in SDNY
As reported in this Newsweek article, former New York Jets defensive end Marvin Washington "is one of five plaintiffs in a federal lawsuit against Sessions, the Department of Justice and the Drug Enforcement Agency" that attacks federal marijuana prohibition on various grounds. Here is a bit more about the lawsuit via the press report:
The Manhattan lawsuit targets the 1970 Controlled Substances Act, which established federal drug policy and delineated narcotics into different schedules. Under the legislation, marijuana is considered a Schedule I controlled substance—along with other drugs such as heroin and ecstasy—and is subjected to the tightest restrictions.... “Classifying cannabis as a ‘Schedule I drug’ is so irrational that it violates the U.S. Constitution,” the lawsuit said.
Washington has joined the lawsuit because the current legislation prevents him from obtaining federal grants to start a business aimed at professional football players who want to use medical marijuana to manage pain.... Other plaintiffs include an 11-year-old boy, Alexis Bortell, who requires medical marijuana to control his epilepsy, and a disabled military veteran, Jose Belen, who uses it to control post traumatic stress syndrome....
Washington, whose playing career ended in 1999, has been a vocal advocate for the use of medical marijuana in football. He has lobbied the NFL to promote medical marijuana as an effective means of pain relief. Washington played eight seasons with the Jets, while also playing for the San Francisco 49ers and the Denver Broncos in a 11-year career. He won the Super Bowl XXXIII in 1999 with the Broncos.
Keith Stroup, legal counsel for the advocacy group NORML, has a lot more of the legal particulars in this new posting which also includes a link to the 89-page complaint in this case. Here are parts of his post:
Washington, et.al v. Sessions, et.al, was recently filed in US District Court in the Southern District of New York by lead attorney Michael Hiller, with NORML Legal Committee (NLC) attorneys David Holland and Joseph Bondy serving as co-counsel. The full complaint can be found here.
Individual plaintiffs in the suit were two young children, an American military veteran, and a retired professional football player, all of whom are medical marijuana patients; and a membership organization alleging their minority members have been discriminated against by the federal Controlled Substances Act.
Seeking to overturn the 2005 Supreme Court decision in Gonzales v. Raich, plaintiffs request a declaration that the CSA, as it pertains to the classification of Cannabis as a Schedule I drug, is unconstitutional, because it violates the Due Process Clause of the Fifth Amendment, an assortment of protections guaranteed by the First Amendment, and the fundamental Right to Travel. Further, plaintiffs seek a declaration that Congress, in enacting the CSA as it pertains to marijuana, violated the Commerce Clause, extending the breadth of legislative power well beyond the scope contemplated by Article I of the Constitution.
Named as defendants in the case are Attorney General Jeff Beauregard Sessions, Acting Administrator of the DEA Chuck Rosenberg, the Justice Department, the DEA and the Federal Government.
In their Complaint, plaintiffs allege that the federal government does not, and could not possibly, believe that Cannabis meets the definition of a Schedule I drug, which is reserved for the most dangerous of substances, such as heroin, LSD, and mescaline; and that classifying Cannabis as a “Schedule I drug,” is so irrational that it violates the U.S. Constitution.
Among the other claims in the lawsuit are that the CSA: (i) was enacted and implemented in order to discriminate against African Americans and to suppress people’s First Amendment rights; and (ii) violates plaintiffs’ constitutional Right to Travel.